While this might seem counterintuitive since glucagon raises blood glucose, the combined effect with GLP-1 and GIP agonism keeps glucose levels in check while dramatically increasing the metabolic rate
Retatrutide is a more recently developed investigational compound a triple agonist targeting the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors simultaneously
BPC-157: Multi-Pathway Cytoprotection The BPC-157 literature describes a peptide that appears to act on several pathways at once rather than through a single receptor
Special Vitamin B12 Combo Deals Disclaimer: The information contained in this website is only for general interest and informational purposes, and is in no way meant to be used to diagnose or prescribe medication or supplementation of any kind to treat any illnesses or symptoms of illnesses
Clinical data on efficacy, side effects, dosing, and costs
IV treatments from our professionals provide many benefits and can increase your overall health and well-being
